AQR CAPITAL MANAGEMENT LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1167557
Greenwich, CT
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,087,377
+$570,385 QoQ
Shares Held
1,394,376
+45.6% QoQ
Ownership
0.808%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 93.18318731819825.ToString("F0")%
Shared 0.ToString("F0")%
None 6.8168126818017525.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. XERS ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in XERS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,087,377 | 1,394,376 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,516,992 | 957,579 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,006,502 | 983,600 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,898,796 | 1,048,993 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,197,743 | 946,766 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,830,446 | 834,940 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,044,129 | 1,068,116 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,684,430 | 1,193,080 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,521,621 | 1,141,006 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $642,071 | 273,222 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $78,640 | 42,280 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,810 | 13,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $51,452 | 31,566 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $66,837 | 50,254 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $32,045 | 20,542 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||